The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?

• Главные авторы: Grace Cuddihy (Автор), Ellen K. Wasan (Автор), Yunyun Di (Автор), Kishor M. Wasan (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2019-02-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Parenteral amphotericin B has been considered as first-line therapy in the treatment of systemic fungal and parasitic infections, however its use has been associated with a number of limitations including affordability, accessibility, and an array of systemic toxicities. Until very recently, it has...